Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus
Clinical trial NCT03753087 · COMPLETED
Trial details
- NCT number
- NCT03753087
- Sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2021-12-16
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.